FDAnews
www.fdanews.com/articles/146008-ims-3-trial-of-mechanical-embolectomy-in-stroke-stopped

IMS 3 Trial of Mechanical Embolectomy in Stroke Stopped

April 30, 2012
The Interventional Management of Stroke 3 (IMS 3) trial, which was comparing intravenous tissue plasminogen activator (tPA) alone with combination tPA and intra-arterial therapy using intra-arterial tPA or mechanical thrombectomy in stroke patients, has suspended enrollment after crossing a prespecified interim analysis threshold.
Medscape Today